GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Danimer Scientific Inc (NYSE:DNMR) » Definitions » EPS (Diluted)

Danimer Scientific (Danimer Scientific) EPS (Diluted) : $-1.52 (TTM As of Dec. 2023)


View and export this data going back to 2020. Start your Free Trial

What is Danimer Scientific EPS (Diluted)?

Danimer Scientific's Earnings per Share (Diluted) for the three months ended in Dec. 2023 was $-0.39. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was $-1.52.

Danimer Scientific's EPS (Basic) for the three months ended in Dec. 2023 was $-0.39. Its EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2023 was $-1.52.

Danimer Scientific's EPS without NRI for the three months ended in Dec. 2023 was $-0.39. Its EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2023 was $-1.52.

During the past 3 years, the average EPS without NRIGrowth Rate was -35.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 5 years, Danimer Scientific's highest 3-Year average EPS without NRI Growth Rate was -35.90% per year. The lowest was -80.60% per year. And the median was -58.25% per year.


Danimer Scientific EPS (Diluted) Historical Data

The historical data trend for Danimer Scientific's EPS (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Danimer Scientific EPS (Diluted) Chart

Danimer Scientific Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
EPS (Diluted)
-0.23 -0.30 -0.65 -1.78 -1.52

Danimer Scientific Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EPS (Diluted) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.28 -0.36 -0.38 -0.39 -0.39

Competitive Comparison of Danimer Scientific's EPS (Diluted)

For the Specialty Chemicals subindustry, Danimer Scientific's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Danimer Scientific's PE Ratio Distribution in the Chemicals Industry

For the Chemicals industry and Basic Materials sector, Danimer Scientific's PE Ratio distribution charts can be found below:

* The bar in red indicates where Danimer Scientific's PE Ratio falls into.



Danimer Scientific EPS (Diluted) Calculation

EPS (Diluted) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Diluted EPS takes into account all of the outstanding dilutive securities that could potentially be exercised (such as stock options and convertible preferred stock) and shows how such an action would impact earnings per share.

Danimer Scientific's Diluted EPS for the fiscal year that ended in Dec. 2023 is calculated as

Diluted EPS (A: Dec. 2023 ) = (Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(-155.473-0)/102.002
=-1.52

Danimer Scientific's Diluted EPS for the quarter that ended in Dec. 2023 is calculated as

Diluted EPS (Q: Dec. 2023 )=(Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(-39.434-0)/102.146
=-0.39

EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-1.52

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Danimer Scientific  (NYSE:DNMR) EPS (Diluted) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Danimer Scientific EPS (Diluted) Related Terms

Thank you for viewing the detailed overview of Danimer Scientific's EPS (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.


Danimer Scientific (Danimer Scientific) Business Description

Traded in Other Exchanges
Address
140 Industrial Boulevard, Bainbridge, GA, USA, 39817
Danimer Scientific Inc creates more sustainable, more natural ways to make plastic products sold under the proprietary Nodax brand name. The company's renewable and sustainable biopolymers have helped create plastic products that are 100% biodegradable and compostable. Danimer Scientific's products return to nature instead of polluting lands and waters. Its technology can be found in a vast array of plastic end-use products that people use every day. Applications for its biopolymers include additives, aqueous coatings, fibers, filaments, films, and injection-molded articles, among others. The company holds more than 470 patents and pending patent applications in nearly 20 countries for a range of manufacturing processes and biopolymer formulations.
Executives
Richard J Hendrix director 1300 NORTH 17TH STREET, ARLINGTON VA 22209
Scott Tuten officer: Chief Marketing Officer 286 DOE RUN DRIVE, CAIRO GA 39828
Gregory W. Hunt director 730 5TH AVENUE, NEW YORK NY 10019
Allison Leopold Tilley director 1300 NORTH 17TH STREET, ARLINGTON VA 22209
Cynthia R Cohen director 1401 BRICKELL AVENUE, SUITE 640, C/O STRATEGIC MINDSHARE, MIAMI FL 33131
John P Amboian director
Michael A Hajost officer: Chief Financial Officer C/O CARPENTER TECHNOLOGY CORPORATION, PO BOX 14662, READING PA 19612-4662
Stephen Croskrey director, officer: CEO & Chairman of the Board C/O ARMOR HOLDINGS INC, 1400 MARSH LANDING PARKWAY SUITE 112, JACKSONVILLE FL 32250
Stuart W Pratt director 303 CONGRESS STREET, BOSTON MA 02210
Van Trump Phillip D officer: Chief Technology Officer 1466 NORTH DECATUR ROAD, ATLANTA GA 30306
Philip Gregory Calhoun director 2100 WHITES BRIDGE ROAD, COLQUITT GA 39837
Isao Noda director 1568 HUNTER ROAD, FAIRFIELD OH 45914
Michael Eric Smith officer: Chief Operating Officer 2208 WYNDHAM WAY, BAINBRIDGE GA 39819
Christy A Basco director 206 WINDING HOLLOW LANE, COPPELL TX 75019
Wunderlich Gary Kent Jr 10 percent owner, officer: President, other: President CLO B. RILEY FINANCIAL, INC.,, 21255 BURBANK BLVD., SUITE 400, WOODLAND CA 91367